A 45-year-old female presents to the emergency department with fever, flank pain, and dysuria. Further evaluation reveals a diagnosis of acute pyelonephritis. Applying knowledge of its pathophysiology, what process is likely occurring in the kidneys during acute pyelonephritis?

A. Mild hypertension can be a cause or a consequence of renal disease, but it is not a specific symptomatic marker for Stage 1. At this early stage, the compensatory mechanisms of the remaining functional nephrons usually prevent overt clinical manifestations of elevated blood pressure. Most patients with a glomerular filtration rate above 90 remain asymptomatic regarding vascular changes.

B. Usually no symptoms are seen at this stage because the kidneys possess a significant functional reserve that masks early damage. Stage 1 is defined by a normal or high glomerular filtration rate (≥ 90 mL/min) with evidence of kidney damage, such as albuminuria. Most individuals are unaware of the condition until it is incidentally discovered during routine laboratory screenings.

C. Hyperphosphatemia typically does not manifest until the later stages of chronic kidney disease, usually Stage 4 or 5. In Stage 1, the kidneys are still sufficiently capable of excreting excess phosphate and maintaining mineral balance through hormonal regulation. Electrolyte imbalances signify a much more advanced degree of nephron loss and a severe decline in filtering capacity.

D. Anemia in chronic kidney disease is primarily caused by a deficiency in erythropoietin production, which generally occurs as the disease progresses to Stage 3. In the initial stage, the peritubular cells are usually still functional enough to stimulate adequate red blood cell production. Clinical anemia is therefore not an expected finding during the very early onset of renal impairment.

A. Elevated high-density lipoprotein (HDL) cholesterol levels: HDL is often referred to as "good" cholesterol because it facilitates the transport of lipids from the tissues back to the liver. High levels of HDL are generally considered cardioprotective and are not a diagnostic criterion for dyslipidemia. Dyslipidemia typically involves a decrease in HDL, which contributes to an increased risk of atherosclerosis.

B. Decreased triglyceride levels: This is not a criterion for dyslipidemia; in fact, dyslipidemia is characterized by hypertriglyceridemia, or elevated levels of triglycerides. High triglyceride levels contribute to the thickening of arterial walls and increase the risk of pancreatitis. Clinicians look for elevations in these fatty acids when diagnosing metabolic syndrome or lipid disorders.

C. Normal total cholesterol levels: By definition, dyslipidemia involves abnormal lipid levels, so normal total cholesterol would not be used to meet the diagnostic criteria for this condition. A diagnosis requires at least one component of the lipid panel, such as LDL, HDL, or triglycerides, to be outside the healthy physiological range. Normal values indicate a healthy lipid metabolism.

D. Elevated low-density lipoprotein (LDL) cholesterol levels: LDL is the primary carrier of cholesterol in the blood and is highly associated with the development of atherosclerotic plaques when present in excess. An elevated LDL level is a central component of the diagnostic criteria for dyslipidemia. Reducing these levels is a primary goal of pharmacologic and lifestyle interventions to prevent cardiovascular disease.